NCT05532683Completed
Feasibility Trial of a Lifestyle Intervention for CHR-P
Development and Feasibility of a Lifestyle Group Intervention for Youth at Clinical High Risk for Psychosis
Source: ClinicalTrials.gov · Last updated 25 Jul 2024
Brief summary (registry, in English)
The present study will assess the feasibility and social validity of an adjunctive health promotion group for youth and clinical high risk for psychosis (CHR-P). Youth participating in treatment at the Center for the Assessment and Prevention of Prodromal Sates (CAPPS) will be invited to participate in a weekly, adjunctive, closed psychoeducation group focused on sharing health promotion strategies and increasing health behaviors (e.g. improved sleep habits, increased participation in physical activity). The aim of the group will be to provide psychoeducation on lifestyle risk and protective factors for youth at risk for psychosis (i.e. experiencing subthreshold psychosis symptoms). Topics covered will include psychoeducation, goal setting, stress management, sleep, physical activity, substance use, and nutrition. Evidence-based strategies to decrease risk factors and promote protective lifestyle factors for mental illness will be reviewed. Group leaders will utilize a motivational interviewing approach to facilitate the group. The group will complete nine weekly group sessions. The goal of our research is to 1) determine the feasibility of a novel group-based health promotion intervention, 2) assess the social validity of the group, 3) measure the effects of the intervention on stress, sleep, physical activity, substance use, and nutrition, and 4) measure preliminary effects on symptoms and functioning.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 1 Aug 2022
- Start date
- 4 Apr 2023
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- University of California, Los Angeles
- Diseases
- Schizophrenia
- NCT number
- NCT05532683
What you commit to
- Study type: Interventional
- Participants enrolled: 9
- From 4 Apr 2023 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- current or lifetime DSM-5 psychotic disorder
- history of neurological disorder
Other
- impaired intellectual functioning (IQ \<65)
- traumatic brain injury (≥7 on TBI screening tool)
- significant substance use that makes CHR-P diagnosis ambiguous
Who the study is looking for
- between 13 and 17 years old
- able to sign and provide informed consent (assent for minors)
- meet criteria for CHR-P using the Structured Interview for Psychosis-Risk Syndromes (SIPS).
- Must have a primary caregiver willing to participate who speaks fluent English
Age in the registry: 13 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California, Los Angeles Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.